Indeed, BRCA-1 downregulation was counteracted by the IRE1 alpha endoribonuclease inhibitor 4μ8c, that also prevented DNA damage in Thapsigargin-treated colon cancer cells. This evidence concerns the gene BRCA1 and colonic neoplasm.